SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-320874
Filing Date
2018-11-07
Accepted
2018-11-07 16:03:54
Documents
53
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d623682d10q.htm 10-Q 634098
2 EX-10.1 d623682dex101.htm EX-10.1 58007
3 EX-10.2 d623682dex102.htm EX-10.2 57184
4 EX-10.3 d623682dex103.htm EX-10.3 54826
5 EX-31.1 d623682dex311.htm EX-31.1 10575
6 EX-31.2 d623682dex312.htm EX-31.2 10569
7 EX-32.1 d623682dex321.htm EX-32.1 4434
8 EX-32.2 d623682dex322.htm EX-32.2 4438
15 GRAPHIC g623682b.jpg GRAPHIC 129240
16 GRAPHIC g623682logo.jpg GRAPHIC 2505
  Complete submission text file 0001193125-18-320874.txt   2770745

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT achn-20180930.xml EX-101.INS 299530
10 XBRL TAXONOMY EXTENSION SCHEMA achn-20180930.xsd EX-101.SCH 25739
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achn-20180930_cal.xml EX-101.CAL 41571
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achn-20180930_def.xml EX-101.DEF 164626
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE achn-20180930_lab.xml EX-101.LAB 228238
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achn-20180930_pre.xml EX-101.PRE 195204
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33095 | Film No.: 181166231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1